| Inhibition of the renin-angiotensin system: no effect on circulating macrophage colony-stimulating factor levels in acute myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 12827024 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Macrophage colony-stimulating factor, which induces proliferation and differentiation, and activation of monocytes and macrophages, plays an important role in the vulnerability of atheromatous plaques as well as the formation of atherosclerotic lesions. We measured serum concentrations of macrophage colony-stimulating factor in patients with acute myocardial infarction and also investigated the effects of early administration of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker on circulating macrophage colony-stimulating factor levels in these patients. The patients were divided randomly into 3 therapeutic groups; perindopril, candesartan, and control (without perindopril and candesartan) groups, and the drugs were administered within 24 to 36 hours after the onset of acute myocardial infarction. Serum macrophage colony-stimulating factor concentrations in acute myocardial infarction patients at the time of admission were significantly higher than those in healthy control subjects. The macrophage colony-stimulating factor levels in the patients decreased gradually after admission, but remained significantly higher than those in control subjects for 14 days. There were no significant differences in serum macrophage colony-stimulating factor levels among the 3 therapeutic groups during this study period. In conclusion, circulating macrophage colony-stimulating factor levels are elevated during the course of acute myocardial infarction, and inhibition of the renin-angiotensin system by angiotensin-converting enzyme inhibitor or angiotensin receptor blocker does not affect these levels. |
| | |
Authors:
|
Kenji Kurosaki; Uichi Ikeda; Yoshiaki Murakami; Masafumi Takahashi; Kazuyuki Shimada |
Related Documents
:
|
1252304 - Significance of serum enzyme changes after cardiac catheterization and selective corona... 6600394 - Alpha 1-antitrypsin in acute myocardial infarction. 6856974 - Serial changes in cytosolic, mitochondrial, and lysosomal enzymes and cardiac myosin li... 642204 - A temporal profile of myocardial zinc changes after isoproterenol induced cardiac necro... 2000744 - Acute hemodynamic effects of intravenous diperdipine, a new dihydropyridine derivative,... 8469914 - Left ventricular end-diastolic dimensions measured at the p wave and q wave during a ra... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Journal of cardiovascular pharmacology Volume: 42 ISSN: 0160-2446 ISO Abbreviation: J. Cardiovasc. Pharmacol. Publication Date: 2003 Jul |
Date Detail:
|
Created Date: 2003-06-26 Completed Date: 2003-11-21 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7902492 Medline TA: J Cardiovasc Pharmacol Country: United States |
Other Details:
|
Languages: eng Pagination: 37-41 Citation Subset: IM |
Affiliation:
|
Division of Cardiovascular Medicine, Jichi Medical School, Tochigi, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Angiotensin-Converting Enzyme Inhibitors / administration & dosage, therapeutic use Antihypertensive Agents / administration & dosage, therapeutic use* Benzimidazoles / administration & dosage, therapeutic use Female Humans Macrophage Colony-Stimulating Factor / blood* Male Middle Aged Myocardial Infarction / blood, drug therapy*, metabolism Perindopril / administration & dosage, therapeutic use Receptors, Angiotensin / antagonists & inhibitors Renin-Angiotensin System / drug effects* Tetrazoles / administration & dosage, therapeutic use Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 0/Benzimidazoles; 0/Receptors, Angiotensin; 0/Tetrazoles; 139481-59-7/candesartan; 81627-83-0/Macrophage Colony-Stimulating Factor; 82834-16-0/Perindopril |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of canrenone on the digitalis site of Na+/K(+)-ATPase in human placental membranes and in ery...
Next Document: Functional comparison of the antagonistic properties of some Angiotensin II type 1 receptor blockers...